Trial NCT01604889

View at ClinicalTrials.gov 
Org. Study IDs: INCB 24360-201

Last trial update was posted on 2019-03-26

MeSH Interventions

Ipilimumab

MeSH Conditions

Melanoma

Other Conditions


Stopping Reasons

Further development of this compound with ipilimumab in the treatment of melanoma is no longer being pursued.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID